Daniel Pink
Impact in
- Gastroenterology top 0.2%
- Gastrointestinal Tumor Research and Treatment
-
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
-
- Gastric Cancer Management and Outcomes 43
- Sarcoma Diagnosis and Treatment 38
- Oncology 49
- Colorectal Cancer Treatments and Studies 14
- Vascular Tumors and Angiosarcomas 12
- Cancer Immunotherapy and Biomarkers 8
- Cancer Treatment and Pharmacology 5
- Co-authors
- Peter Reichardt (70 shared papers)Peter Hohenberger (32 shared papers)Eva Wardelmann (14 shared papers)Peter Thuss‐Patience (31 shared papers)Albrecht Kretzschmar (16 shared papers)Bernd Dörken (6 shared papers)Dimosthenis Andreou (20 shared papers)Per‐Ulf Tunn (8 shared papers)
- Journals
- Journal of Clinical Oncology (40 papers)Annals of Oncology (18 papers)European Journal of Cancer (6 papers)Cancers (5 papers)Clinical Cancer Research (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Daniel Pink
123 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 153
- Gastroenterology 1.1k
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 526
- Obstetrics and Gynecology 119
- Rheumatology 221
Countries citing papers authored by Daniel Pink
This map shows the geographic impact of Daniel Pink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Pink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Pink more than expected).
Fields of papers citing papers by Daniel Pink
This network shows the impact of papers produced by Daniel Pink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Pink. The network helps show where Daniel Pink may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Pink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Whole New Mind: Why Right Brainers will Rule the Future | 2006 | 429 |
| 2 | 2006 | 276 | |
| 3 | 2010 | 156 | |
| 4 | 2015 | 150 | |
| 5 | 2017 | 135 | |
| 6 | 2005 | 127 | |
| 7 | 2008 | 124 | |
| 8 | 2011 | 108 | |
| 9 | 2003 | 103 | |
| 10 | 2017 | 91 | |
| 11 | 2005 | 85 | |
| 12 | 2009 | 84 | |
| 13 | 2020 | 62 | |
| 14 | 2014 | 54 | |
| 15 | 2013 | 46 | |
| 16 | 2012 | 45 | |
| 17 | 2014 | 39 | |
| 18 | 2011 | 39 | |
| 19 | 2015 | 36 | |
| 20 | 2013 | 33 |
About Daniel Pink
Daniel Pink is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Gastroenterology, Surgery and Hematology, having authored 132 papers that have together received 3.1k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (49 papers), Gastric Cancer Management and Outcomes (43 papers), Sarcoma Diagnosis and Treatment (38 papers), Colorectal Cancer Treatments and Studies (14 papers), Esophageal Cancer Research and Treatment (14 papers), Vascular Tumors and Angiosarcomas (12 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Gastroenterology (1.1k citations), Pulmonary and Respiratory Medicine (1.4k citations), Oncology (526 citations), Obstetrics and Gynecology (119 citations) and Rheumatology (221 citations). Daniel Pink has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Peter Reichardt, Peter Hohenberger, Eva Wardelmann, Peter Thuss‐Patience, Albrecht Kretzschmar, Bernd Dörken, Dimosthenis Andreou, Per‐Ulf Tunn, Mathias Werner and Sebastian Bauer. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancers and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.